What was the recent performance of SMS Pharmaceuticals Limited on the NSE?

The stock surged by 18%, closing at INR 322.30 with significantly high trading volumes of 11.76 million shares, indicating strong market interest and participation.

What are the key financial metrics of SMS Pharmaceuticals?

The company reports an Earnings Per Share of INR 9.67 and a PE ratio of 33.33. It has a market cap of approximately INR 28.73 billion, with a Return on Equity of 12.16%.

How does the current technical analysis look for SMSPHARMA.NS?

Technically, the stock shows strong bullish momentum with an RSI of 69 and ADX of 33.03, suggesting a robust trend. The volatility is reflected in the ATR of 14.28.

What is driving the Indian pharmaceutical sector’s growth?

Growth is driven by increased healthcare demand, favorable export policies, and expanding API production capabilities. Companies like SMS Pharmaceuticals are well-positioned to benefit from these trends.

What are the future prospects for SMS Pharmaceuticals Limited according to market analysts?

Analysts, utilizing insights from platforms like Meyka AI, foresee a year-end target price in the INR 340-350 range, driven by robust earnings and market positioning.

IN Stocks

SMS Pharmaceuticals Limited Surges 18% Amid High Trading Volume: A Technical and Fundamental Overview

ByHuzaifa Zahoor November 27, 2025November 27, 2025

SMS Pharmaceuticals Limited (SMSPHARMA.NS) has recently caught investor attention with an 18% jump in its stock price, closing at INR 322.30 on the NSE. This movement was accompanied by a massive trading volume, indicating heightened interest among traders and investors.